Literature DB >> 17679119

Hyponatremia: clinical diagnosis and management.

Yeong-Hau H Lien1, Joseph I Shapiro.   

Abstract

Hyponatremia is a common clinical problem in hospitalized patients and nursing home residents. It also may occur in healthy athletes after endurance exercise. The majority of patients with hyponatremia are asymptomatic and do not require immediate correction of hyponatremia. Symptomatic hyponatremia is a medical emergency requiring rapid correction to prevent the worsening of brain edema. How fast we should increase the serum sodium levels depends on the onset of hyponatremia and still remains controversial. If the serum sodium levels are corrected too rapidly, patients may develop central pontine myelinolysis, but if they are corrected too slowly, patients may die of brain herniation. We review the epidemiology and mechanisms of hyponatremia, the sensitivity of women to hyponatremic injury, the adaptation and maladaptation of brain cells to hyponatremia and its correction, and the practical ways of managing hyponatremia. Because the majority of hyponatremia is caused by the non-osmotic release of vasopressin, the recent approval of the vasopressin receptor antagonist conivaptan for euvolemic hyponatremia may simplify hyponatremia management. However, physicians should be aware of the risk of rapid correction of hyponatremia, hypotension, and excessive fluid intake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679119     DOI: 10.1016/j.amjmed.2006.09.031

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

Review 1.  Receptor regulation of osmolyte homeostasis in neural cells.

Authors:  Stephen K Fisher; Anne M Heacock; Richard F Keep; Daniel J Foster
Journal:  J Physiol       Date:  2010-05-24       Impact factor: 5.182

2.  Subacute alteration in level of consciousness in a woman with psychotic depression.

Authors:  Zainab Samaan; Glenda Macqueen
Journal:  J Psychiatry Neurosci       Date:  2008-05       Impact factor: 6.186

Review 3.  Volume-dependent osmolyte efflux from neural tissues: regulation by G-protein-coupled receptors.

Authors:  Stephen K Fisher; Tooba A Cheema; Daniel J Foster; Anne M Heacock
Journal:  J Neurochem       Date:  2008-06-02       Impact factor: 5.372

Review 4.  Postmortem diagnosis of hyponatremia: case report and literature review.

Authors:  Jessica Vanhaebost; Cristian Palmiere; Maria Pia Scarpelli; Fabiola Bou Abdallah; Arnaud Capron; Gregory Schmit
Journal:  Int J Legal Med       Date:  2017-05-13       Impact factor: 2.686

5.  Body sodium, potassium and water in peritoneal dialysis-associated hyponatremia.

Authors:  Yijuan Sun; David Mills; Todd S Ing; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  Perit Dial Int       Date:  2014-05       Impact factor: 1.756

6.  Muscarinic receptor stimulation of D-aspartate uptake into human SH-SY5Y neuroblastoma cells is attenuated by hypoosmolarity.

Authors:  Daniel J Foster; Anne M Heacock; Stephen K Fisher
Journal:  J Pharmacol Exp Ther       Date:  2010-01-15       Impact factor: 4.030

7.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

8.  Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells.

Authors:  Daniel J Foster; Victor M Vitvitsky; Ruma Banerjee; Anne M Heacock; Stephen K Fisher
Journal:  J Neurochem       Date:  2008-10-08       Impact factor: 5.372

Review 9.  Hyponatremia in acute heart failure syndromes: a potential therapeutic target.

Authors:  Filippo Brandimarte; Francesco Fedele; Leonardo De Luca; Gregg C Fonarow; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2007-12

10.  Tolvaptan and its potential in the treatment of hyponatremia.

Authors:  Megan B Dixon; Y Howard Lien
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.